AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| PEB | PEB Investor Update - April 2018 | |||
| PEB | SPH Notice - First NZ Capital Group Limited | |||
| PEB | PE Receives Approval for New CPT Codes from AMA | |||
| PEB | SPH Notice - AMP Capital Investors (New Zealand) Limited | |||
